Ashwagandha Extract for Weight and Stress Management in Overweight and Obese Adults

Korábbi kezelés

• Taking nutritional or energy supplements, medication, or steroids,
• Participation in other clinical trials during previous 3 months

Más betegség

• History of Alcohol or smoking abuse.
• History of hypersensitivity to Ashwagandha
• Any history of drug abuse
• Participants who use medication for blood pressure, use beta-blockers, inhaled any beta-agonists, use any hormonal contraceptives, having a history of corticosteroid use within three months, participants under psychotropic medication within last 8 weeks
• Participants diagnosed with any heart disease, diabetes, stroke, neurological disorders or depression.
• Have clinically significant acute unstable hepatic, renal, cardiovascular, or respiratory disease that will prevent participation in the study.
• Patients with depressive episode, panic disorder, social phobia, obsessive-compulsory disorder, alcohol dependency; schizophrenia and mania.
• Patients with post traumatic disorder.
• Any clinical condition, according to the investigator which does not allow safe fulfilment of clinical trial protocol.

Egyéb

• Having any clinical abnormalities
• Simultaneously participating in any other clinical trial or participated in the past three months
• Have an established practice of meditation (as meditating for at least 20 minutes, three or more times per week) for three or more months.
• Pregnant and lactating women

• Healthy adult men and women participants ≥ 19 years and ≤65 years of age.
• Willingness to follow the protocol requirements as evidenced by written informed consent.
• Participants willing to give meaningful, written informed consent prior to participation in the trial, in accordance with regulatory requirements.
• Participants who agree to take investigational product (i.e., Till Week 8).
• Participants with Body mass index between 25 and 39.9 kg/m2